Human colonic epithelial cells detect and respond to C5a via apically expressed C5aR through the ERK pathway

American Journal of Physiology - Cell Physiology

Volumn 302, Issue 12, 2012, Pages

  Cao, Qi ^a   Mcisaac, Shayla M ^a   Stadnyk, Andrew W ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

C5a receptor; Chemokine; Colitis; Epithelium; Extracellular related kinase

Indexed keywords

C5L2 PROTEIN; COMPLEMENT COMPONENT C5A RECEPTOR; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE PERMEABILITY; COLON MUCOSA; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CACO-2 CELLS; CELL POLARITY; CELL PROLIFERATION; COLON; COMPLEMENT ACTIVATION; COMPLEMENT C5A; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HT29 CELLS; HUMANS; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INFLAMMATION; INTERLEUKIN-8; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MAP KINASE SIGNALING SYSTEM; PERMEABILITY; PHENOTYPE; PROTEIN KINASE INHIBITORS; RECEPTORS, CHEMOKINE; RECEPTORS, COMPLEMENT; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

EID: 84862610368     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00213.2011     Document Type: Article

References (58)

1. Abe K, Miyazaki M, Koji T, Furusu A, Nakamuro-Kurashige T, Nishino T, Ozono Y, Harada T, Sakai H, Kohno S. Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization. Kidney Int 60: 137-146, 2001.
2. Abe M, Hama H, Shirakusa T, Iwasaki A, Ono N, Kimura N, Hugi T, Okada N, Katsuragi T, Okada H. Contribution of anaphylatoxins to allergic inflammation in human lungs. Microbiol Immunol 49: 981-986, 2005.
3. Abreu M, Vora P, Faure E, Thomas L, Arnold E, Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 167: 1609-1616, 2001.
4. Adams R, Planchon S, Roche J. IFN-gamma modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. J Immunol 150: 2356-2363, 1993.
5. Andoh A, Fujiyama Y, Bamba T, Hosoda S. Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. J Immunol 151: 4239-4247, 1993.
6. Bamberg C, Mackay C, Lee H, Zahra D, Jackson J, Lim Y, Whitfeld P, Craig S, Corsini E, Lu B, erard C, Gerard N. The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J Biol Chem 285: 7633-7644, 2010.
7. Bernet-Camard M, Coconnier M, Hudault S, Servin A. Differential expression of complement proteins and regulatory decay accelerating factor in relation to differentiation of cultured human colon adenocarci-noma cell lines. Gut 38: 248-253, 1996.
8. Berstad A, Brandtzaeg P. Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract. Gut 42: 522-529, 1998.
9. Berstad A, Brandtzaeg P, Stave R, Halstensen T. Epithelium related deposition of activated complement in Helicobacter pylori associated gastritis. Gut 40: 196-203, 1997.
10. Buhl A, Avdi N, Worther G, Johnson G. Mapping of the C5a receptor signal transduction network in human neutrophils. Proc Natl Acad Sci USA 91: 9190-9194, 1994.
11. Chen G, Yang Y, Gao X, Dou Y, Wang H, Han G, Wang R, Wang J, Wang L, Li X, Guo R, Xiao H, Shen B, Li Y. Blockade of complement activation product C5a activity using specific antibody attenuates intestinal damage in trinitrobenzene sulfonic acid induced model of colitis. Lab Invest 91: 472-483, 2011.
12. Chen N, Mirtsos C, Suh D, Lu Y, Lin W, McKerlie C, Lee T, Baribault H, Tian H, Yeh W. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 446: 203-207, 2007.
13. DeWire S, Ahn S, Lefkowitz R, Shenoy S. Beta-arrestins and cell signaling. Annu Rev Physiol 69: 483-510, 2007.
14. Drouin S, Kildsgaard J, Haviland J, Zabner J, Jia H, McCray PJ, Tack B, Wetsel R. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J Immunol 166: 2025-2032, 2001.
15. Fayyazi A, Scheel O, Werfel T, Schweyer S, Oppermann M, Gotze O, Radzun H, Zwirner J. The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells. Immunology 99: 38-45, 2000.
16. Floreani A, Heires A, Welniak L, Miller-Lindholm A, Clark-Pierce L, Rennard S, Morgan E, Sanderson S. Expression of receptors for C5a anaphylatoxin (CD88) on human bronchial epithelial cells: enhancement of C5a-mediated release of IL-8 upon exposure to cigarette smoke. J Immunol 160: 5073-5081, 1998.
17. Frank M, Fries L. The role of complement in inflammation and phagocytosis. Immunol Today 12: 322-326, 1991.
18. Fukuoka Y, Medof E. C5a receptor-mediated production of IL-8 by the human retinal pigment epithelial cell line, ARPE-19. Curr Eye Res 23: 320-325, 2001.
19. Gallagher R, Kellym C, Neville S, Sheils O, Weir D, Feighery C. Complement activation within the coeliac small intestine is localised to Brunner's glands. Gut 30: 1568-1573, 1989.
20. Gewirtz A, Navas T, Lyons S, Godowski P, Madara J. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 167: 1882-1885, 2001.
21. Grootjans J, Lenaerts K, Derikx JP, Matthijsen RA, de Bruïne AP, van Bijnen AA, van Dam RM, Dejong CH, Buurman WA. Human intestinal ischemia-reperfusion-induced inflammation characterized: experiences from a new translational model. Am J Pathol 176: 2283-2291, 2010.
22. Grossmann J, Maxson JM, Whitacre CM, Orosz DE, Berger NA, Fiocchi C, Levine AD. New isolation technique to study apoptosis in human intestinal epithelial cells. Am J Pathol 153: 53-62, 1998.
23. Halstensen T, Brandtzaeg P. Local complement activation in inflammatory bowel disease. Immunol Res 10: 485-492, 1991.
24. Halstensen T, Mollnes T, Brandtzaeg P. Persistent complement activation in submucosal blood vessels of active inflammatory bowel disease: immunohistochemical evidence. Gastroenterology 97: 10-19, 1989.
25. Halstensen T, Mollnes T, Garred P, Fause O, Brandtzaeg P. Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis. Gastroenterology 98: 1264-1271, 1990.
26. Haviland D, McCoy R, Whitehead W, Akama H, Molmenti E, Brown A, Haviland J, Parks W, Perlmutter D, Wetsel R. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J Immunol 15: 1861-1869, 1995.
27. Ia Sala A, Gadina M, Kelsall B. G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK. J Immunol 175: 2994-2999, 2005.
28. Johswich K, Martin M, Bleich A, Kracht M, Dittrich-Breiholz O, Gessner J, Suerbaum S, Wende E, Rheinheimer C, Klos A. Role of the C5a receptor (C5aR) in acute and chronic dextran sulfate-induced models of inflammatory bowel disease. Inflamm Bowel Dis 15: 1812-1823, 2009.
29. Klos A, Tenner A, Johswich K, Ager R, Reis E, Kohl J. The role of the anaphylatoxins in health and disease. Mol Immunol 46: 2753-2766, 2009.
30. Kolios G, Petoumenos C, Nakos A. Mediators of inflammation: production and implication in inflammatory bowel disease. Hepatogastroenter-ology 45: 160-169, 1998.
31. Lee H, Whitfeld P, Mackay C. Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2. Immunol Cell Biol 86: 153-160, 2008.
32. Lipschutx J, Li S, Ariscom A, Balkovetz D. Extracellular signal-regulated kinases 1/2 control claudin-2 expression in Madin-Darby canine kidney strain I and II cells. J Biol Chem 280: 3780-3788, 2005.
33. Magalhaes J, Tattoli I, Girardin S. The intestinal epithelial barrier: how to distinguish between the microbial flora and pathogens. Semin Immunol 19: 106-115, 2007.
34. McKay D, Watson J, Wang A, Caldwell J, Prescott D, Ceponis P, Di Leo V, Lu J. Phosphatidylinositol 3′-kinase is a critical mediator of interferon-gamma-induced increases in enteric epithelial permeability. J Pharmacol Exp Ther 320: 1013-1022, 2007.
35. Melmed G, Thomas L, Lee N, Tesfay S, Lukasek K, Michelsen K, Zhou Y, Hu B, Arditi M, Abreu M. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 170: 1406-1415, 2003.
36. Monsinjon T, Gasque P, Chan P, Ischenko A, Brady J, Fontaine M. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells. FASEB J 17: 1003-1014, 2003.
37. Mukherjee P, Pasinetti G. Complement anaphylatoxin C5a neuropro-tects through mitogen-activated protein kinase-dependent inhibition of caspase 3. J Neurochem 77: 43-49, 2001.
38. Ohno M, Hirata T, Enomoto M, Araki T, Ishimaru H, Takahashi T. A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells. Mol Immunol 37: 407-412, 2000.
39. Riedemann N, Guo R, Sarma V, Laudes I, Huber-Lang M, Warner R, Albrecht E, Speyer C, Ward P. Expression and function of the C5a receptor in rat alveolar epithelial cells. J Immunol 168: 1919-1925, 2002.
40. Rollins T, Siciliano S, Kobayashi S, Cianciarulo D, Bonilla-Argudo V, Collier K, Springer M. Purification of the active C5a receptor from human polymorphonuclear leukocytes as a receptor-Gi complex. Proc Natl Acad Sci USA 88: 971-975, 1991.
41. Rothermel E, Götze O, Zahn S, Schlaf G. Analysis of the tissue distribution of the rat C5a receptor and inhibition of C5a-mediated effects through the use of two MoAbs. Scand J Immunol 52: 401-410, 2000.
42. Roussear S, Dolado I, Beardmore V, Shpiro N, Marquez R, Nevreda A, Arthur J, Case L, Tessier-Lavigne M, Gaestel M, Cuenda A, Cohen P. CXCL12 and C5a trigger cell migration via a PAK1/2-p38alpha MAPK-MAPKAP-K2-HSP27 pathway. Cell Signal 18: 1897-1905, 2006.
43. Sacks S. Complement fragments C3a and C5a: the salt and pepper of the immune response. Eur J Immunol 40: 668-670, 2010.
44. Servant G, Weiner O, Herzmark P, Balla T, Sedat J, Bourne H. Polarization of chemoattractant receptor signaling during neutrophil che-motaxis. Science 287: 1037-1040, 2000.
45. Shen L, Turner J. Role of epithelial cells in initiation and propagation of intestinal inflammation. Eliminating the static: tight junction dynamics exposed. Am J Physiol Gastrointest Liver Physiol 290: G577-G582, 2006.
46. Strohmeyer R, Shen Y, Rogers J. Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain. Brain Res Mol Brain Res 81: 7-18, 2000.
47. Sun L, Gao H, Sarma V, Guo R, Ward P. Adenovirus-mediated in vivo silencing of anaphylatoxin receptor C5aR. J Biomed Biotechnol 2006: 28945-28954, 2006.
48. Sun L, Guo R, Gao H, Sarma J, Zetoune F, Ward P. Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells. FASEB J 23: 3808-3818, 2009.
49. Tsukita S, Yamazaki Y, Katsuno T, Tamura A, Tsukita S. Tight junction-based epithelial microenvironment and cell proliferation. Onco-gene 27: 6930-6938, 2008.
50. Ueki T, Mizuno M, Uesu T, Kiso T, Nasu J, Inaba T, Kihara Y, Matsuoka Y, Okada H, Fujita T, Tsuji T. Distribution of activated complement, C3b, and its degraded fragments, iC3b/C3dg, in the colonic mucosa of ulcerative colitis (UC). Clin Exp Immunol 104: 286-292, 1996.
51. Uesu T, Mizuno M, Inoue H, Tomoda J, Tsuji T. Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis. Lab Invest 72: 587-591, 1995.
52. Van Itallie C, Anderson J. Claudins and epithelial paracellular transport. Annu Rev Physiol 68: 403-429, 2006.
53. Wang Y, Zhang J, Yi X, Yu F. Activation of ERK1/2 MAP kinase pathway induces tight junction disruption in human corneal epithelial cells. Exp Eye Res 78: 125-136, 2004.
54. Wetsel R. Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells. Immunol Lett 44: 183-187, 1995.
55. Woodruff T, Pollitt S, Proctor L, Stocks S, Manthey H, Williams H, Mahadevan I, Shiels I, Taylor S. Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease. J Pharmacol Exp Ther 314: 811-817, 2005.
56. Yang R, Harada T, Li J, Uchiyama T, Han Y, Englert J, Fink M. Bile modulates intestinal epithelial barrier function via an extracellular signal related kinase 1/2 dependent mechanism. Intensive Care Med 31: 709- 717, 2005.
57. Zheng X, Zhang X, Feng B, Sun H, Suzuki M, Ichim T, Kubo N, Wong A, Min L, Budohn M, Garcia B, Jevnikar A, Min W. Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury. Am J Pathol 173: 973-980, 2008.
58. Zwirner J, Fayyazi A, Götze O. Expression of the anaphylatoxin C5a receptor in non-myeloid cells. Mol Immunol 36: 877-884, 1999.